Microbio Statistics

Total Valuation

Microbio has a market cap or net worth of TWD 19.44 billion. The enterprise value is 17.76 billion.

Market Cap	19.44B
Enterprise Value	17.76B

Important Dates

The next estimated earnings date is Friday, March 7, 2025.

Earnings Date	Mar 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Microbio has 588.17 million shares outstanding. The number of shares has decreased by -0.00% in one year.

Current Share Class	n/a
Shares Outstanding	588.17M
Shares Change (YoY)	-0.00%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	0.08%
Owned by Institutions (%)	7.29%
Float	428.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	11.56
PB Ratio	1.78
P/TBV Ratio	1.81
P/FCF Ratio	43.27
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-20.32
EV / Sales	10.56
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	39.52

Financial Position

The company has a current ratio of 8.63, with a Debt / Equity ratio of 0.05.

Current Ratio	8.63
Quick Ratio	8.10
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	1.33
Interest Coverage	-26.26

Financial Efficiency

Return on equity (ROE) is -8.15% and return on invested capital (ROIC) is -1.20%.

Return on Equity (ROE)	-8.15%
Return on Assets (ROA)	-1.11%
Return on Capital (ROIC)	-1.20%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.12
Inventory Turnover	5.45

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.89% in the last 52 weeks. The beta is 1.37, so Microbio's price volatility has been higher than the market average.

Beta (5Y)	1.37
52-Week Price Change	-29.89%
50-Day Moving Average	37.69
200-Day Moving Average	39.41
Relative Strength Index (RSI)	30.13
Average Volume (20 Days)	1,863,884

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Microbio had revenue of TWD 1.68 billion and -873.89 million in losses. Loss per share was -1.49.

Revenue	1.68B
Gross Profit	648.19M
Operating Income	-259.65M
Pretax Income	-1.06B
Net Income	-873.89M
EBITDA	-160.52M
EBIT	-259.65M
Loss Per Share	-1.49

Full Income Statement

Balance Sheet

The company has 3.89 billion in cash and 597.23 million in debt, giving a net cash position of 3.29 billion or 5.59 per share.

Cash & Cash Equivalents	3.89B
Total Debt	597.23M
Net Cash	3.29B
Net Cash Per Share	5.59
Equity (Book Value)	12.50B
Book Value Per Share	18.53
Working Capital	3.93B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 494.26 million and capital expenditures -44.98 million, giving a free cash flow of 449.28 million.

Operating Cash Flow	494.26M
Capital Expenditures	-44.98M
Free Cash Flow	449.28M
FCF Per Share	0.76

Full Cash Flow Statement

Margins

Gross margin is 38.54%, with operating and profit margins of -15.44% and -51.96%.

Gross Margin	38.54%
Operating Margin	-15.44%
Pretax Margin	-62.94%
Profit Margin	-51.96%
EBITDA Margin	-9.54%
EBIT Margin	-15.44%
FCF Margin	26.71%

Dividends & Yields

Microbio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.00%
Shareholder Yield	0.00%
Earnings Yield	-4.51%
FCF Yield	2.31%

Dividend Details

Stock Splits

The last stock split was on August 29, 2024. It was a forward split with a ratio of 1.049999998.

Last Split Date	Aug 29, 2024
Split Type	Forward
Split Ratio	1.049999998

Scores

Microbio has an Altman Z-Score of 7.76.

Altman Z-Score	7.76
Piotroski F-Score	n/a